Position in KRYS
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$448,605
+$110,981 QoQ
Shares Held
1,207
-7.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#254
of 419 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Net Worth Advisory Group holds $1,018,645 across 2 Biotechnology names. KRYS ranks #2 (44.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
7,283 | $570,040 | |
| 2 | KRYS |
Krystal Biotech, Inc.
This page
|
1,207 | $448,605 |
All Filings in KRYS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $448,605 | 1,207 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $337,624 | 1,307 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $227,556 | 923 | Shares | Sole | 2026-01-14 | |
| No filing history on record for this holder in this stock. | ||||||